Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8712)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol 2014; 20(12): 3100-3111 [PMID: 24696597 DOI: 10.3748/wjg.v20.i12.3100] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3100.htm |
| Number | Citing Articles |
| 1 |
Bulat Ibragimov, Diego A. S. Toesca, Yixuan Yuan, Albert C. Koong, Daniel T. Chang, Lei Xing. Neural Networks for Deep Radiotherapy Dose Analysis and Prediction of Liver SBRT Outcomes. IEEE Journal of Biomedical and Health Informatics 2019; 23(5): 1821 doi: 10.1109/JBHI.2019.2904078
|
| 2 |
Svetlana Kuznetsova, Petra Grendarova, Rishi Sinha, Nicolas Ploquin, Kundan Thind. Auto-delineation framework for the focal liver reaction observed in post Stereotactic Body Radiation Therapy (SBRT) Primovist MRI scans. Medical Dosimetry 2022; 47(1): 1 doi: 10.1016/j.meddos.2021.06.005
|
| 3 |
Cristina Talarico, Lucia D’Antona, Domenica Scumaci, Agnese Barone, Francesco Gigliotti, Claudia Vincenza Fiumara, Vincenzo Dattilo, Enzo Gallo, Paolo Visca, Francesco Ortuso, Claudia Abbruzzese, Lorenzo Botta, Silvia Schenone, Giovanni Cuda, Stefano Alcaro, Cataldo Bianco, Patrizia Lavia, Marco G. Paggi, Nicola Perrotti, Rosario Amato. Preclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progressionin vitroandin vivoand synergizes with radiotherapy. Oncotarget 2015; 6(35): 37511 doi: 10.18632/oncotarget.5527
|
| 4 |
Dagmar Kollmann, Nazia Selzner, Markus Selzner. Bridging to liver transplantation in HCC patients. Langenbeck's Archives of Surgery 2017; 402(6): 863 doi: 10.1007/s00423-017-1609-2
|
| 5 |
Hsin-Lun Lee, Jo-Ting Tsai, Chun-You Chen, Ying-Chun Lin, Chin-Beng Ho, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Chun-Yu Lin, Jui-Hsiang Tang, Yu-Min Huang, Wei-Yu Kao, Sheng-Wei Cheng, Chia-Ning Shen, Shang-Wen Chen, Jeng-Fong Chiou. Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization. Therapeutic Advances in Medical Oncology 2019; 11 doi: 10.1177/1758835919889002
|
| 6 |
Chai Hong Rim, Chul Yong Kim, Dae Sik Yang, Won Sup Yoon. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review. Radiotherapy and Oncology 2018; 129(1): 112 doi: 10.1016/j.radonc.2017.11.013
|
| 7 |
Chai Hong Rim, Hyung Joon Yim, Sunmin Park, Jinsil Seong. Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta‐analyses. Journal of Medical Imaging and Radiation Oncology 2019; 63(6): 812 doi: 10.1111/1754-9485.12948
|
| 8 |
Gwyneth S.T. Soon, Saba Yasir, Tsung-Teh Wu, Christopher Welle, Sudhakar K. Venkatesh, Michael S. Torbenson, Zongming Eric Chen. Unique Morphologic Findings in the Liver After Stereotactic Radiation for Cholangiocarcinoma. American Journal of Surgical Pathology 2023; 47(7): 792 doi: 10.1097/PAS.0000000000002052
|
| 9 |
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin. The management of post-transplantation recurrence of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(1): 1 doi: 10.3350/cmh.2021.0217
|
| 10 |
Yiqing Xu, Ashrei Bayewitz, Magdalena Tary-Lehmann. Rapid Dissemination followed by Spontaneous Regression of Metastatic Hepatocellular Carcinoma after Liver Radiofrequency Thermal Ablation: A Case Report with Correlative Immune Assay. Case Reports in Oncology 2023; : 135 doi: 10.1159/000527229
|
| 11 |
Michael J. Gutman, Lucas M. Serra, Matthew Koshy, Rohan R. Katipally. SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know. Seminars in Interventional Radiology 2024; 41(01): 001 doi: 10.1055/s-0043-1778657
|
| 12 |
Jeongshim Lee, In-Soo Shin, Won Sup Yoon, Woong Sub Koom, Chai Hong Rim. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review. Radiotherapy and Oncology 2020; 145: 63 doi: 10.1016/j.radonc.2019.12.004
|
| 13 |
Kyung In Shin, Byoung Kuk Jang, Jin Hee Kim, Jae Seok Hwang. Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy. Journal of Liver Cancer 2020; 20(2): 167 doi: 10.17998/jlc.20.2.167
|
| 14 |
Yukinori Matsuo. Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview. Current Oncology 2023; 30(2): 2493 doi: 10.3390/curroncol30020190
|
| 15 |
Nikolaos Galanakis, Elias Kehagias, Nikolas Matthaiou, Dimitrios Samonakis, Dimitrios Tsetis. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepatic Oncology 2018; 5(2) doi: 10.2217/hep-2018-0001
|
| 16 |
Tai‐Ze Yuan, Ze‐Jiang Zhan, Chao‐Nan Qian. New frontiers in proton therapy: applications in cancers. Cancer Communications 2019; 39(1): 1 doi: 10.1186/s40880-019-0407-3
|
| 17 |
Chai Hong Rim, Hyun Ju Kim, Jinsil Seong. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. Radiotherapy and Oncology 2019; 131: 135 doi: 10.1016/j.radonc.2018.12.005
|
| 18 |
Namita E. Mathew, Mohammad Elsayed, Nariman Nezami, Bill S. Majdalany, Ripal Gandhi, Michael Haber, Zachary L. Bercu, Nima Kokabi. Systematic Review of Radiation-Based Therapies for Hepatocellular Carcinoma. Digestive Disease Interventions 2021; 5(02): 123 doi: 10.1055/s-0041-1728807
|
| 19 |
Akanksha Sharma, Ashish Verma, Rishabha Malviya, Shalini Yadav. Deep Learning for Targeted Treatments. 2022; : 247 doi: 10.1002/9781119857983.ch9
|
| 20 |
Eun Kyung Paik, Mi-Sook Kim, Won Il Jang, Young Seok Seo, Chul-Koo Cho, Hyung Jun Yoo, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Young Han Kim. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma. Radiation Oncology 2016; 11(1) doi: 10.1186/s13014-016-0597-7
|
| 21 |
Baek Gyu Jun, Sang Gyune Kim, Young Don Kim, Gab Jin Cheon, Koon Hee Han, Jeong-Ju Yoo, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Suyeon Park, Hong Soo Kim, Gianfranco D. Alpini. Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis. PLOS ONE 2018; 13(10): e0206381 doi: 10.1371/journal.pone.0206381
|
| 22 |
Philippe d’Abadie, Stephan Walrand, Michel Hesse, Laurence Annet, Ivan Borbath, Marc Van den Eynde, Renaud Lhommel, François Jamar. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nuclear Medicine Communications 2021; 42(7): 747 doi: 10.1097/MNM.0000000000001395
|
| 23 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 24 |
Makiko Urabe, Hayato Hikita, Yoshinobu Saito, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuta Myojin, Akira Doi, Katsuhiko Sato, Sadatsugu Sakane, Yuki Makino, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver. Hepatology Communications 2022; 6(2): 411 doi: 10.1002/hep4.1815
|
| 25 |
Nicole E. Rich, Adam C. Yopp, Amit G. Singal. Medical Management of Hepatocellular Carcinoma. Journal of Oncology Practice 2017; 13(6): 356 doi: 10.1200/JOP.2017.022996
|
| 26 |
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?. International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
|
| 27 |
Evelyn Herrmann, Diana Naehrig, Manfred Sassowsky, Martin Bigler, Jeroen Buijsen, Ilja Ciernik, Daniel Zwahlen, Alessandra Franzetti Pellanda, Andreas Meister, Peter Brauchli, Simona Berardi, Erika Kuettel, Jean-François Dufour, Daniel M. Aebersold. External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-016-0745-0
|
| 28 |
Berardino De Bari, Mahmut Ozsahin, Pierre Bize, Tarek Boussaha, Gaël Deplanque, Dorothea Wagner, Jean Bourhis, Alban Denys. Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?. Journal of Clinical Oncology 2016; 34(23): 2798 doi: 10.1200/JCO.2016.66.7196
|
| 29 |
Jérôme Doyen, Alexander Tuan Falk, Vincent Floquet, Joël Hérault, Jean-Michel Hannoun-Lévi. Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy. Cancer Treatment Reviews 2016; 43: 104 doi: 10.1016/j.ctrv.2015.12.007
|
| 30 |
Mustafa M. Haddad, Kenneth W. Merrell, Christopher L. Hallemeier, Geoffrey B. Johnson, Taofic Mounajjed, Kenneth R. Olivier, Jeff L. Fidler, Sudhakar K. Venkatesh. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdominal Radiology 2016; 41(10): 2061 doi: 10.1007/s00261-016-0768-x
|
| 31 |
Chai Hong Rim, Jinsil Seong. Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines. Radiation Oncology Journal 2016; 34(3): 160 doi: 10.3857/roj.2016.01970
|
| 32 |
Xiao-fei Zhang, Lin Lai, Hui Zhou, Yuan-jun Mo, Xu-quan Lu, Min Liu, Yun-xin Lu, En-cun Hou, Gregory Tiao. Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis. PLOS ONE 2022; 17(5): e0268779 doi: 10.1371/journal.pone.0268779
|
| 33 |
Nalee Kim, Hyun Ju Kim, Jong Yun Won, Do Young Kim, Kwang-Hyub Han, Inkyung Jung, Jinsil Seong. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. Radiotherapy and Oncology 2019; 131: 81 doi: 10.1016/j.radonc.2018.12.013
|
| 34 |
Katerina Mastrocostas, Hyun-Jung Jang, Sandra Fischer, Laura A. Dawson, Pablo Munoz-Schuffenegger, Gonzalo Sapisochin, Tae Kyoung Kim. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls. Abdominal Radiology 2019; 44(5): 1795 doi: 10.1007/s00261-019-01901-y
|
| 35 |
Huimei Zhang, Na Chang, Tiantian Han, Shaodi Ma, Guangbo Qu, Haixia Liu, Chenyu Sun, Ce Cheng, Qin Zhou, Yehuan Sun. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for hepatocellular carcinoma: a meta-analysis. Future Oncology 2021; 17(30): 4027 doi: 10.2217/fon-2021-0263
|
| 36 |
Zong-ming Zhang, Eric C.H. Lai, Chong Zhang, Hong-wei Yu, Zhuo Liu, Bo-jiang Wan, Li-min Liu, Zu-hao Tian, Hai Deng, Qiu-hong Sun, Xiao-ping Chen. The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. International Journal of Surgery 2015; 20: 8 doi: 10.1016/j.ijsu.2015.05.009
|
| 37 |
Marta Scorsetti, Tiziana Comito, Luca Cozzi, Elena Clerici, Angelo Tozzi, Ciro Franzese, Pierina Navarria, Antonella Fogliata, Stefano Tomatis, Giuseppo D’Agostino, Cristina Iftode, Pietro Mancosu, Roberto Ceriani, Guido Torzilli. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT). Journal of Cancer Research and Clinical Oncology 2015; 141(7): 1301 doi: 10.1007/s00432-015-1929-y
|
| 38 |
Jared H. Gans, Jeffrey Lipman, Yosef Golowa, Milan Kinkhabwala, Andreas Kaubisch. Hepatic Cancers Overview: Surgical and Chemotherapeutic Options, How Do Y-90 Microspheres Fit in?. Seminars in Nuclear Medicine 2019; 49(3): 170 doi: 10.1053/j.semnuclmed.2019.01.001
|
| 39 |
Toshihiro Furuta, Masayuki Yamaguchi, Manabu Minami, Osamu Abe, Hirofumi Fujii. Treatment margins in radiotherapy for liver tumors visualized as T2*-hypointense areas on SPIO-enhanced MRI at 9.4 T. Magnetic Resonance Materials in Physics, Biology and Medicine 2020; 33(5): 701 doi: 10.1007/s10334-020-00838-4
|
| 40 |
Sun Hyun Bae, Mi-Sook Kim, Won Il Jang, Chul-Seung Kay, Woochul Kim, Eun Seog Kim, Jin Ho Kim, Jin Hee Kim, Kwang Mo Yang, Kyu Chan Lee, A Ram Chang, Sunmi Jo. Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group. Japanese Journal of Clinical Oncology 2016; 46(4): 363 doi: 10.1093/jjco/hyv209
|
| 41 |
J. Jacob, F. Nguyen, É. Deutsch, F. Mornex. Place de la radiothérapie stéréotaxique dans la prise en charge des tumeurs hépatiques. Cancer/Radiothérapie 2014; 18(5-6): 486 doi: 10.1016/j.canrad.2014.07.145
|
| 42 |
Lior Charach, Zusmanovitch Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment. EMJ Hepatology 2017; : 89 doi: 10.33590/emjhepatol/10312792
|
| 43 |
Hao Niu, Li Zhang, Yu-Han Chen, Bao-Ying Yuan, Zhi-Feng Wu, Jason Chia-Hsien Cheng, Qin Lin, Zhao-Chong Zeng. Circular RNA TUBD1 Acts as the miR-146a-5p Sponge to Affect the Viability and Pro-Inflammatory Cytokine Production of LX-2 Cells through the TLR4 Pathway. Radiation Research 2020; 193(4): 383 doi: 10.1667/RR15550.1
|
| 44 |
Hikaru Niitsu, Masashi Mizumoto, Yinuo Li, Masatoshi Nakamura, Toshiki Ishida, Takashi Iizumi, Takashi Saito, Haruko Numajiri, Hirokazu Makishima, Kei Nakai, Yoshiko Oshiro, Kazushi Maruo, Hideyuki Sakurai. Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma. Cancers 2024; 16(2): 357 doi: 10.3390/cancers16020357
|
| 45 |
Puja S. Venkat, Sarah E. Hoffe, Jessica M. Frakes. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control 2017; 24(3): 107327481772925 doi: 10.1177/1073274817729259
|
| 46 |
Aseel Y. Abualnil, Ritesh Kumar, Mridula A. George, Alexander Lalos, Mihir M. Shah, Matthew P. Deek, Salma K. Jabbour. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 173 doi: 10.1016/j.soc.2023.06.012
|
| 47 |
Mingxuan Chen, Yongheng An, Hongsheng Yu, Yifan Li, Xiaoman Chen. Damage to Wistar rat livers after hypo-fractionated radiation and oxaliplatin. Oncology and Translational Medicine 2015; 1(3): 130 doi: 10.1007/s10330-015-0070-3
|
| 48 |
Kin Pan Au, Kenneth Siu Ho Chok. Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm. World Journal of Gastroenterology 2018; 24(45): 5081-5094 doi: 10.3748/wjg.v24.i45.5081
|
| 49 |
Kazue Shiozawa, Manabu Watanabe, Takashi Ikehara, Yasushi Matsukiyo, Michio Kogame, Yui Kishimoto, Yusuke Okubo, Hiroyuki Makino, Nobuhiro Tsukamoto, Yoshinori Igarashi, Yasukiyo Sumino. Comparison of percutaneous radiofrequency ablation and CyberKnife<sup>®</sup> for initial solitary hepatocellular carcinoma: A pilot study. World Journal of Gastroenterology 2015; 21(48): 13490-13499 doi: 10.3748/wjg.v21.i48.13490
|
| 50 |
Wei-Xiang Qi, Shen Fu, Qing Zhang, Xiao-Mao Guo. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis. Radiotherapy and Oncology 2015; 114(3): 289 doi: 10.1016/j.radonc.2014.11.033
|
| 51 |
Hiroshi Doi, Norihisa Masai, Kenji Uemoto, Osamu Suzuki, Hiroya Shiomi, Daisaku Tatsumi, Ryoong-Jin Oh. Validation of the liver mean dose in terms of the biological effective dose for the prevention of radiation-induced liver damage. Reports of Practical Oncology & Radiotherapy 2017; 22(4): 303 doi: 10.1016/j.rpor.2017.02.011
|
| 52 |
Myungsoo Kim, Chul Seung Kay, Won Il Jang, Mi-Sook Kim, Dong Soo Lee, Hong Seok Jang. Prognostic value of tumor volume and radiation dose in moderate-sized hepatocellular carcinoma. Medicine 2017; 96(24): e7202 doi: 10.1097/MD.0000000000007202
|
| 53 |
Aleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach, Charles B Simone. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression. Future Oncology 2023; 19(4): 279 doi: 10.2217/fon-2022-0893
|
| 54 |
Chai Hong Rim, Chul Yong Kim, Dae Sik Yang, Won Sup Yoon. External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: A meta-analysis and systemic review. Radiotherapy and Oncology 2018; 129(1): 123 doi: 10.1016/j.radonc.2018.02.030
|
| 55 |
Hiroshi Doi, Hiroya Shiomi, Ryoong-Jin Oh. Management of Chronic Liver Diseases - Recent Advances. 2018; doi: 10.5772/intechopen.76505
|
| 56 |
Katsumaro Kubo, Tomoki Kimura, Hiroshi Aikata, Shigeo Takahashi, Yuki Takeuchi, Ippei Takahashi, Ikuno Nishibuchi, Yuji Murakami, Kazuaki Chayama, Yasushi Nagata. Long‐term outcome of stereotactic body radiotherapy for patients with small hepatocellular carcinoma. Hepatology Research 2018; 48(9): 701 doi: 10.1111/hepr.13063
|
| 57 |
Jongmoo Park, Jae Won Park, Min Kyu Kang. Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma. Yeungnam University Journal of Medicine 2019; 36(3): 192 doi: 10.12701/yujm.2019.00269
|
| 58 |
Alessia Guarneri, Pierfrancesco Franco, Elisabetta Trino, Daniela Campion, Riccardo Faletti, Stefano Mirabella, Silvia Gaia, Riccardo Ragona, Margherita Diotallevi, Giorgio Saracco, Mauro Salizzoni, Umberto Ricardi, Patrizia Carucci. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm. Medical Oncology 2016; 33(10) doi: 10.1007/s12032-016-0823-z
|
| 59 |
Marc Ziegler, Tobias Brandt, Sebastian Lettmaier, Rainer Fietkau, Christoph Bert. Performance of gimbal-based dynamic tumor tracking for treating liver carcinoma. Radiation Oncology 2018; 13(1) doi: 10.1186/s13014-018-1180-1
|